Demant ASCHIX:DEMANC +10.96%94 Receivables Turnover is 3.22 as of Dec. 2025. GuruFocus rates CHIX:DEMANC with a GF Score™ of 94/100 and a GF Value™ of kr314.25 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 813 Medical Devices & Instruments companies, Demant AS ranks better than 61.25% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Demant AS's Revenue for the
six
months ended in Dec. 2025 was kr11,718 Mil. Demant AS's average Accounts Receivable for the
six
months ended in Dec. 2025 was kr3,634 Mil.
Hence, Demant AS's Receivables Turnover for the
six
months ended in Dec. 2025 was 3.22.
Demant AS (CHIX:DEMANc) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Demant AS Receivables Turnover Related Terms
Demant AS Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Demant AS's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:DEMANC vs ABT, SYK, MDT: Receivables Turnover Comparison
For the Medical Devices subindustry, Demant AS's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Demant AS Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Demant AS's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Demant AS's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Demant AS (CHIX:DEMANC) has a Receivables Turnover of 3.22 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Demant AS and its competitors. According to the industry distribution chart, Demant AS ranks #315 out of 813 companies in the Medical Devices & Instruments industry, placing it in the top 38.7%.
Is Demant AS's Receivables Turnover too high?
Demant AS's current Receivables Turnover is 3.22. The Medical Devices & Instruments industry median Receivables Turnover is 5.51. Demant AS's value of 3.22 is 41.6% below this industry median. Based on the distribution chart, Demant AS ranks #315 out of 813 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Demant AS has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Demant AS's Receivables Turnover compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Demant AS ranks #315 out of 813 companies for Receivables Turnover. This puts Demant AS in the upper half of its industry. The industry median Receivables Turnover is 5.51. Demant AS's value of 3.22 is 41.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.51, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Demant AS's current Receivables Turnover of 3.22 is 41.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Demant AS and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Demant AS's current Receivables Turnover is 3.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Demant AS stock overvalued right now?
Based on GuruFocus' analysis, Demant AS (CHIX:DEMANC) is currently considered Modestly Undervalued. The stock's GF Value™ is kr314.25, compared to a current price of kr273.40 — trading 13% below its estimated fair value. The current Receivables Turnover is 3.22 and 41.6% below the Medical Devices & Instruments industry median of 5.51. Demant AS's overall GF Score™ is 94/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Demant AS (CHIX:DEMANC), the current Receivables Turnover is 3.22 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Demant AS (CHIX:DEMANC) Overvalued in 2026?
Based on GuruFocus' analysis, Demant AS stock appears to be undervalued.
The current stock price of kr273.40 is trading 13% below its estimated GF Value™ of kr314.25.
GuruFocus considers Demant AS to be Modestly Undervalued.
Key valuation signals for CHIX:DEMANC:
Receivables Turnover: 3.22
GF Value™: kr314.25 vs. price of kr273.40 (13% below fair value)
Industry Position: 41.6% below the Medical Devices & Instruments median (#315 of 813)
No single metric tells the full story. See the CHIX:DEMANC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Demant is a Denmark-based manufacturer and distributor of hearing solutions, such as hearing aid devices and diagnostic equipment. More than 80% of the company's sales come from North America and Europe.
94GF Score
Get the complete analysis for CHIX:DEMANC
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:DEMANC has been successfully added to your 
